{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T02:35:04Z","timestamp":1760150104805,"version":"build-2065373602"},"reference-count":27,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T00:00:00Z","timestamp":1697760000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCDD"],"abstract":"<jats:p>(1) Background: A plethora of studies have elucidated the safety and efficacy of catheter ablation (CA) for patients afflicted with atrial fibrillation (AF) and concomitant reduction in left ventricular ejection fraction (LVEF). Nevertheless, the literature on the benefits of CA in the specific etiological context of heart failure (HF) remains limited. This study delineates a comparative assessment of outcomes for patients with AF and reduced LVEF across the primary etiologies. (2) Methods: Our inquiry encompassed 216 patients diagnosed with congestive heart failure and an LVEF of less than 50 percent who were referred to our institution for circumferential pulmonary vein isolation (CPVI) between the years 2016 and 2020. The selection criteria included a detailed medical history while excluding those suffering from valvular disease, congenital heart disease, and hypertrophic cardiomyopathy. In an effort to scrutinize varying etiologies, patients were stratified into three categories: dilated cardiomyopathy (DCM, n = 56, 30.6%), ischemic cardiomyopathy (ICM, n = 68, 37.2%), and tachycardia-induced cardiomyopathy (TIC, n = 59, 32.2%). (3) Results: Following an average (\u00b1SD) duration of 36 \u00b1 3 months, the prevalence of sinus rhythm was 52.1% in the DCM group, 50.0% in the ICM group, and 68.14% in the TIC group (p = 0.014). This study revealed a significant disparity between the DCM and TIC groups (p = 0.021) and the ICM and TIC groups (p = 0.007), yet no significant distinction was discerned between the TIC and ICM groups (p = 0.769). Importantly, there were no significant variations in the application of antiarrhythmic drugs or recurrence of procedures among the three groups. The mortality rates were 14.29% for the DCM group and 14.71% for the ICM group, which were higher than the 3.39% observed in the TIC group (DCM vs. TIC p = 0.035 (HR = 4.50 (95%CI 1.38\u201314.67)), ICM vs. TIC p = 0.021 (HR = 5.00 (95%CI 1.61\u201315.50))). A noteworthy enhancement in heart function was evidenced in the TIC group in comparison to the DCM and ICM groups, including a higher LVEF (p &lt; 0.001), diminution of LV end-diastolic diameter (p &lt; 0.001), and an enhanced New York Heart Association classification (p = 0.005). Hospitalization rates for heart failure were discernibly lower in TIC patients (0.98 (0,2) times) relative to those with DCM (1.74 (0,3) times, p &lt; 0.01) and TIC (1.78 (0,4) times, p &lt; 0.001). Patients with paroxysmal atrial fibrillation and brief episodes were found to achieve superior clinical outcomes through a catheter ablation strategy. (4) Conclusion: Patients diagnosed with TIC demonstrated a more pronounced benefit from catheter ablation compared to those with DCM and ICM. This encompassed an augmented improvement in cardiac function, an enhanced maintenance of sinus rhythm, and a reduced mortality rate.<\/jats:p>","DOI":"10.3390\/jcdd10100437","type":"journal-article","created":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T07:25:22Z","timestamp":1697786722000},"page":"437","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Benefit of Catheter Ablation for Atrial Fibrillation in Heart Failure Patients with Different Etiologies"],"prefix":"10.3390","volume":"10","author":[{"given":"Songbing","family":"Long","sequence":"first","affiliation":[{"name":"Department of Cardiovascular, The Central Hospital of Shaoyang, Shaoyang 422000, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3490-2523","authenticated-orcid":false,"given":"Yuanjun","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular, The First Affiliated Hospital of Dalian Medical University, Dalian 116011, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianjie","family":"Xiao","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular, The First Affiliated Hospital of Dalian Medical University, Dalian 116011, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongzhen","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular, The First Affiliated Hospital of Dalian Medical University, Dalian 116011, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular, The First Affiliated Hospital of Dalian Medical University, Dalian 116011, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lianjun","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular, The First Affiliated Hospital of Dalian Medical University, Dalian 116011, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunlong","family":"Xia","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular, The First Affiliated Hospital of Dalian Medical University, Dalian 116011, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1897-7448","authenticated-orcid":false,"given":"Xiaomeng","family":"Yin","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular, The First Affiliated Hospital of Dalian Medical University, Dalian 116011, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,10,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1161\/01.CIR.0000072767.89944.6E","article-title":"Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: The Framingham Heart Study","volume":"107","author":"Wang","year":"2003","journal-title":"Circulation"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/eurjhf\/hfp085","article-title":"A meta-analysis of the prognostic significance of atrial fibrillation in chronic heart failure","volume":"11","author":"Mamas","year":"2009","journal-title":"Eur. J. Heart Fail."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.hfc.2009.11.001","article-title":"Atrial fibrillation in congestive heart failure","volume":"6","author":"Lubitz","year":"2010","journal-title":"Heart Fail. Clin."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1161\/CIRCHEARTFAILURE.111.962688","article-title":"Atrial fibrillation and mortality in heartfailure: A community study","volume":"4","author":"Chamberlain","year":"2011","journal-title":"Circ. Heart Fail."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e005694","DOI":"10.1161\/JAHA.112.005694","article-title":"Cardiovascular Research Network PRESERVE Study. Atrial fibrillation and outcomes in heart failure with preserved versus reduced left ventricular ejection fraction","volume":"2","author":"McManus","year":"2013","journal-title":"J. Am. Heart Assoc."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1056\/NEJMoa1602014","article-title":"Cryoballoon or radiofrequency ablation for paroxysmal atrial fibrillation","volume":"374","author":"Kuck","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/j.jacc.2013.01.069","article-title":"A randomized trial to assess catheter ablation versus rate control in the management of persistent atrial fibrillation in heart failure","volume":"61","author":"Jones","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/clc.23314","article-title":"Safety and efficacy of catheter ablation in atrial fibrillation patients with left ventricular dysfunction","volume":"43","author":"Long","year":"2020","journal-title":"Clin. Cardiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1161\/CIRCULATIONAHA.115.019406","article-title":"Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients with Congestive HeartFailure and an Implanted Device: Results From the AATAC Multicenter Randomized Trial","volume":"133","author":"Mohanty","year":"2016","journal-title":"Circulation"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMoa1707855","article-title":"Catheter Ablation for Atrial Fibrillation with Heart Failure","volume":"378","author":"Marrouche","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e007731","DOI":"10.1161\/CIRCEP.119.007731","article-title":"Catheter Ablation Versus Best Medical Therapy in Patients with Persistent Atrial Fibrillation and Congestive Heart Failure: TheRandomized AMICA Trial","volume":"12","author":"Kuck","year":"2019","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1161\/CIRCULATIONAHA.120.050991","article-title":"Ablation Versus Drug Therapy for Atrial Fibrillation in Heart Failure","volume":"143","author":"Packer","year":"2021","journal-title":"Circulation"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ijcard.2022.04.040","article-title":"A new prediction model for left ventricular systolic function recovery after catheter ablation of atrial fibrillation in patients with heart failure: The ANTWOORD Study","volume":"358","author":"Bergonti","year":"2022","journal-title":"Int. J. Cardiol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/0002-9343(49)90397-6","article-title":"Auricular fibrillation without other evidence of heart disease","volume":"7","author":"Phillips","year":"1949","journal-title":"Am. J. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41572-019-0084-1","article-title":"Dilated cardiomyopathy","volume":"5","author":"Schultheiss","year":"2019","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_16","first-page":"528","article-title":"2012 HRS\/EHRA\/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: Recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design","volume":"14","author":"Calkins","year":"2012","journal-title":"J. Interv. Card. Electrophysiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1093\/europace\/euv440","article-title":"Catheter ablation of atrial fibrillation in patients with heart failure: Impact of maintaining sinus rhythm on heart failure status and long-term rates of stroke and death","volume":"18","author":"Ullah","year":"2016","journal-title":"Europace"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"4093","DOI":"10.1016\/j.ijcard.2013.07.017","article-title":"Impact of atrial fibrillation-induced tachycardiomyopathy in patients undergoing pulmonary vein isolation","volume":"168","author":"Calvo","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1111\/jce.14144","article-title":"Comparison of atrial arrhythmia recurrence after persistent atrial fibrillation ablation between patients with or without tachycardia-induced cardiomyopathy","volume":"30","author":"Yamashita","year":"2019","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1111\/jce.12765","article-title":"Six-Year Clinical Outcomes After Catheter Ablation of Atrial Fibrillation in Patients With Impaired Left Ventricular Function","volume":"26","author":"Rillig","year":"2015","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1093\/europace\/euaa036","article-title":"Long-term effectiveness of catheter ablation in patients with atrial fibrillation and heart failure","volume":"22","author":"Samuel","year":"2020","journal-title":"Europace"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1056\/NEJMoa2019422","article-title":"EAST-AFNET 4 Trial Investigators. Early Rhythm-Control Therapy in Patients with Atrial Fibrillation","volume":"383","author":"Kirchhof","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/europace\/euac173","article-title":"Catheter ablation improves cardiovascular outcomes in patients with atrial fibrillation and heart failure: A meta-analysis of randomized controlled trials","volume":"25","author":"Simader","year":"2023","journal-title":"Europace"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/europace\/euac186","article-title":"Atrial fibrillation onset before heart failure or vice versa: What is worst? A nationwide register study","volume":"25","author":"Pallisgaard","year":"2023","journal-title":"Europace"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/europace\/euac255","article-title":"Atrial fibrillation and heart failure temporality: Does it matter?","volume":"25","author":"Rienstra","year":"2023","journal-title":"Europace"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/j.jacc.2017.08.041","article-title":"Catheter ablation versus medical rate control in atrial fibrillation and systolic dysfunction: The CAMERA-MRI study","volume":"70","author":"Prabhu","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1161\/CIRCEP.113.000806","article-title":"A randomized controlled trial of catheter ablation versus medical treatment of atrial fibrillation in heart failure (the CAMTAF trial)","volume":"7","author":"Hunter","year":"2014","journal-title":"Circ. Arrhythm. Electrophysiol."}],"container-title":["Journal of Cardiovascular Development and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2308-3425\/10\/10\/437\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:10:14Z","timestamp":1760130614000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2308-3425\/10\/10\/437"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,20]]},"references-count":27,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2023,10]]}},"alternative-id":["jcdd10100437"],"URL":"https:\/\/doi.org\/10.3390\/jcdd10100437","relation":{},"ISSN":["2308-3425"],"issn-type":[{"type":"electronic","value":"2308-3425"}],"subject":[],"published":{"date-parts":[[2023,10,20]]}}}